Medical and Hospital News
SPACE MEDICINE
ISS National Lab and NASA Announce Funding for Space-Based Research on Disease Treatment
illustration only
ISS National Lab and NASA Announce Funding for Space-Based Research on Disease Treatment
by Clarence Oxford
Los Angeles CA (SPX) Aug 16, 2024
The International Space Station (ISS) National Laboratory is partnering with NASA to launch a new research solicitation focused on tackling major diseases such as cancer, cardiovascular disease, and neurodegenerative disorders. The ISS National Lab Research Announcement (NLRA) 2024-09, titled "Igniting Innovation: Science in Space to Cure Disease on Earth," has been released in collaboration with NASA's Biological and Physical Sciences division. The initiative aims to address the barriers that hinder advancements in disease prevention, diagnosis, and treatment. Up to $4 million in total funding will be made available, with an expected two to three awards for multiflight research and technology development projects.

The ISS National Lab and NASA are seeking proposals that harness the unique environment of space to develop new or enhance existing technologies that can help solve health challenges on Earth. Diseases such as cancer, cardiovascular conditions, immune disorders, muscle and bone degeneration, and neurodegenerative diseases often face common obstacles that impede scientific progress and the clinical application of research findings. Utilizing accelerated disease models in the microgravity environment of the ISS could help mitigate these challenges.

This NLRA encourages collaboration among academic institutions, industry, and government entities to create innovative, commercially viable products and technologies aimed at improving health outcomes on Earth. Key areas of interest for this research announcement include:

- Enhanced Models to Study Disease Mechanisms: Unraveling the complexities of disease onset and progression to identify therapeutic targets is challenging. Microgravity could enhance cell-based models, such as tissue chips and organoids, to provide deeper insights into disease mechanisms, potentially leading to personalized therapies.

- Population and Disease Heterogeneity: The variability in genetic and demographic factors, including age and sex, complicates drug discovery and treatment efficacy. Addressing this heterogeneity is crucial for developing more effective therapies.

- Drug Screening and Development: The space environment allows for high-throughput drug screening using 3D cell cultures and tissue models that better mimic the human body. Innovative technologies are needed to accelerate the identification of preclinical drug candidates.

- Drug Delivery: Advances in drug delivery, such as nanotechnology and targeted therapies, are essential to improve treatment precision and minimize side effects. The discovery of new biomarkers is also critical to enhance treatment outcomes.

- Drug Resistance and Toxicity: Drug resistance, particularly in cancer treatment, poses significant challenges, as cells can adapt and reduce drug efficacy. Additionally, the toxicity of treatments like chemotherapy requires careful management to balance effectiveness with adverse effects.

At the ISS Research and Development Conference held in Boston last month, the ISS National Lab and NASA unveiled five projects selected through the first Igniting Innovation NLRA, which focuses on leveraging the space environment to advance cancer research for the benefit of patients on Earth.

"We are proud to collaborate again this year with NASA's Biological and Physical Sciences division on this important initiative to bring the transformative power of space-based inquiry into the fight against diseases that touch all of our lives," said ISS National Lab Chief Scientific Officer Michael Roberts. "Our inaugural solicitation in 2023 resulted in the selection of five innovative concepts to leverage microgravity and the space station to benefit patients on Earth. We look forward to enabling access to even more ideas that ignite innovation and fuel research and development for the benefit of humanity."

"Space-based research has a long history of contributing to advancements on Earth," added Lisa Carnell, director of NASA's Biological and Physical Sciences division. "Continuing the Igniting Innovation solicitation could contribute to the next big leap in disease therapies. We are excited to collaborate with the ISS National Lab on this endeavor to help address some of the biggest health challenges facing the world today."

The NLRA follows a three-step proposal submission process: Step 1A involves submitting a Concept Summary, Step 1B requires a Technology Roadmap, and Step 2 is the Full Proposal. Concept Summaries for Step 1A must be submitted by the end of the day on September 26, 2024.

Interested parties can learn more about this research announcement by registering for a webinar hosted by the ISS National Lab on August 22, 2024, at 1 p.m. EDT.

Research Opportunity:NLRA 2024-9 Igniting Innovation: Science In Space To Cure Disease On Earth

Related Links
International Space Station (ISS) National Laboratory
Space Medicine Technology and Systems

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
SPACE MEDICINE
MD Anderson teams with experts to study T-cells on ISS
Los Angeles CA (SPX) Aug 01, 2024
The University of Texas MD Anderson Cancer Center, along with several collaborators, is launching a research initiative that will send T cells to the International Space Station (ISS) to investigate the effects of prolonged microgravity on cell differentiation, activation, memory, and exhaustion. Results will be analyzed on Earth to uncover signaling pathways and identify potential immune targets, aiming to enhance treatment strategies for cancer and other diseases. Leading this effort, MD Anderso ... read more

SPACE MEDICINE
Pakistan's Sindh orders inquiry into monsoon child brides

Japan to begin trial removal of nuclear debris from Fukushima reactor

Regional power sharing could reduce outage risks by 40 percent

Turkey gold mine in landslide disaster lays off workers

SPACE MEDICINE
UK to build military test site to combat GPS jamming

US Air Force working with SandboxAQ to enhance AQNav GPS protection

US, Australia collaborate to enhance GPS resilience in contested environments

oneNav's Advanced L5 Technology Mitigates GPS Jamming in Israel

SPACE MEDICINE
Apes to stay at home as Malaysia tweaks 'orangutan diplomacy'

Neanderthal Adaptability Unveiled at Ancient Pyrenees Site

Discovery of the Smallest Arm Bone Illuminates Evolution of Homo floresiensis

Chinese woman loses appeal for right to freeze her eggs

SPACE MEDICINE
Hong Kong welcomes birth of first giant panda cubs

Scientists prepared to save monarch butterfly in event of 'rapid extinction'

California zoo throws a show to welcome back Chinese pandas

Gunfire, bombs as Colombia guerrillas flex muscles ahead of COP16

SPACE MEDICINE
China to screen arrivals for mpox symptoms

'Hong Kong's Dr Fauci' sounds alarm on next pandemic

Polio virus found as flies and mosquitoes feast on Gaza's waste

Decade since Ebola, Sierra Leone fights another deadly fever

SPACE MEDICINE
China's 'throwing eggs' card game wins fans and official censure

Macau leader Ho Iat-seng won't seek second term

China sentences ex-football official to 11 years for corruption

Stressed China youth fuel wellness boom with traditional twist

SPACE MEDICINE
Pay up or move out: Drug gangs rob Ecuadorans of homes

UN warns Iraq becoming major regional drug conduit

Guns n' ganja: Weapons flood Catalonia's cannabis trade

Spain, France bust million-euro-a-day money laundering network

SPACE MEDICINE
Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2026 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.